ISSN: 2155-9554
+44 1478 350008
Head R&D Centre, Ari Healthcare Pvt. Ltd., India
Research Article
Evaluation of Efficacy and Safety of AHPL/AYCAP/0413 Capsule and AHPL/ AYTOP/0213 Cream in Patients Suffering from Acne Vulgaris
Author(s): Sanjay U Nipanikar*, Vaishali Deshpande and Chopade HS
Background: Available treatments for acne vulgaris are associated with various adverse effects, which necessitate
patients to opt for alternative treatment options.
Objectives: To evaluate efficacy and safety of AHPL/AYCAP/0413 capsule and AHPL/AYTOP/0213 cream in
subjects suffering from Acne Vulgaris.
Method: A total of 62 subjects completed the study. Subjects were advised to take 2 capsules of AHPL/AYCAP/0413
twice daily orally after meals with water and apply AHPL/AYTOP/0213 cream all over the face twice a day for two
months or complete resolution of acne whichever was earlier. The primary objective was to assess changes in total
number of inflammatory acne lesions on face. Secondary objectives were to assess changes in total numbers of noninflammatory
acne lesions, total lesion count (inf.. View More»
DOI:
10.35248/2155-9554.20.11.525